Document Type

Article

Publication Date

12-1-2020

Comments

This article is the author’s final published version in Chinese Clinical Oncology, Volume 9, Issue 6, December 2020, Article number 74.

The published version is available at https://doi.org/10.21037/cco.2020.03.05. Copyright © Chinese Clinical Oncology.

Abstract

High grade gliomas (HGG) have a propensity to recur locally and have poor outcomes. As such, safe and effective treatment is paramount. Target treatment with stereotactic radiation allows safe re-irradiation through minimizing normal brain tissue radiation due to its high precision. In this review, we evaluated the clinical experiences using SRS and FSRT for re-irradiation in HGG. We report the radiobiological advantages and disadvantages of both modalities as well as the safety and efficacy published in current literature.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

PubMed ID

32389000

Language

English

COinS